Human Tetanus Immune Globulin (TIG) is a preparation derived from the plasma of immunized donors. It contains antibodies that are specifically targeted against the tetanus toxin. These antibodies provide passive immunity by neutralizing the toxin, thus preventing the progression of the disease. TIG is a critical component in the management of suspected tetanus exposure, particularly in individuals who are inadequately vaccinated.
